Analyst Price Targets — GILD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 19, 2026 9:18 pm | — | Barclays | $155.00 | $151.12 | TheFly | Gilead initiated with an Equal Weight at Barclays |
| February 19, 2026 12:20 pm | — | Mizuho Securities | $170.00 | $152.74 | TheFly | Gilead price target raised to $170 from $140 at Mizuho |
| February 18, 2026 12:02 pm | — | UBS | $175.00 | $155.27 | TheFly | Gilead price target raised to $175 from $155 at UBS |
| February 11, 2026 2:28 pm | Louise Chen | Scotiabank | $177.00 | $155.29 | TheFly | Gilead price target raised to $177 from $140 at Scotiabank |
| February 11, 2026 2:27 pm | Courtney Breen | Bernstein | $160.00 | $155.45 | StreetInsider | Gilead Sciences (GILD) PT Raised to $160 at Bernstein SocGen Group |
| February 11, 2026 2:07 pm | — | Morgan Stanley | $171.00 | $155.72 | TheFly | Gilead price target raised to $171 from $150 at Morgan Stanley |
| February 11, 2026 1:36 pm | — | Truist Financial | $162.00 | $155.87 | StreetInsider | Gilead Sciences (GILD) PT Raised to $162 at BofA Securities |
| February 11, 2026 1:31 pm | — | Truist Financial | $152.00 | $154.69 | TheFly | Gilead price target raised to $152 from $145 at Truist |
| February 11, 2026 1:13 pm | — | Oppenheimer | $165.00 | $153.46 | TheFly | Gilead price target raised to $165 from $128 at Oppenheimer |
| February 11, 2026 12:43 pm | — | Cantor Fitzgerald | $155.00 | $147.23 | TheFly | Gilead price target raised to $155 from $135 at Cantor Fitzgerald |
Latest News for GILD
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
FOSTER CITY, Calif.--(BUSINESS WIRE)--GILEAD FOUNDATION AWARDS $12 MILLION TO EMPOWER COMMUNITY HEALTH WORKERS AND EXPAND HIV PREVENTION INITIATIVES ACROSS THE US.
The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9.7% yield and -10% NAV discount. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than…
Weekly Market HighlightsMarket breadth was slightly positive with 4,817 advancers versus 4,692 decliners, but performance was highly skewed as the mean weekly
CNBC's Julia Boorstin sits down with Johanna Mercier, Chief Commercial & Corporate Affairs Officer at Gilead Sciences, who works to end HIV in our lifetime. Mercier explains how managing her energy helps her in her career.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.